A phase III randomized, double-blind, placebo-controlled trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïvepts with bone predominant metastatic castration-resistant prostate cancer (CRPC)
- Pook, David (Primary Chief Investigator (PCI))
Project: Research